| Literature DB >> 33475929 |
Daniela Fernanda Dezotti Silva1, Lucas de Oliveira Fujii1, Gabriela Bortolança Chiarotto1, Camila Andrea de Oliveira1, Thiago Antônio Moretti de Andrade1, Alexandre Leite Rodrigues de Oliveira2, Marcelo Augusto Marretto Esquisatto1, Fernanda Aparecida Sampaio Mendonça1, Gláucia Maria Tech Dos Santos1, Andrea Aparecida de Aro3,4.
Abstract
The literature has shown the beneficial effects of microcurrent (MC) therapy on tissue repair. We investigated if the application of MC at 10 μA/90 s could modulate the expression of remodeling genes transforming growth factor beta (Tgfb), connective tissue growth factor (Ctgf), insulin-like growth factor 1 (Igf1), tenascin C (Tnc), Fibronectin (Fn1), Scleraxis (Scx), Fibromodulin (Fmod) and tenomodulin in NIH/3T3 fibroblasts in a wound healing assay. The cell migration was analyzed between days 0 and 4 in both fibroblasts (F) and fibroblasts + MC (F+MC) groups. On the 4th day, cell viability and gene expression were also analyzed after daily MC application. Higher expression of Ctgf and lower expression of Tnc and Fmod, respectively, were observed in the F+MC group in relation to F group (p < 0.05), and no difference was observed between the groups for the genes Tgfb, Fn1 and Scx. In cell migration, a higher number of cells in the scratch region was observed in group F+MC (p < 0.05) compared to group F on the 4th day, and the cell viability assay showed no difference between the groups. In conclusion, MC therapy at an intensity/time of 10 μA/90 s with 4 daily applications did not affect cell viability, stimulated fibroblasts migration with the involvement of Ctgf, and reduced the Tnc and Fmod expression.Entities:
Keywords: Cell migration; Fibroblasts; Genes; Microcurrent; Therapy
Mesh:
Substances:
Year: 2021 PMID: 33475929 DOI: 10.1007/s11033-021-06135-0
Source DB: PubMed Journal: Mol Biol Rep ISSN: 0301-4851 Impact factor: 2.316